PaedsCalc
Pediatric Clinical Dose Calculator
Point-of-care clinical tools to evaluate chronic symptom control and triage acute pediatric wheezing attacks.
Evaluate pediatric asthma control in the past 4 weeks (GINA Guidelines):
Patient demonstrates good asthma control. Maintain current controller regimen. Reassess in 3β6 months.
Clinical severity staging for acute pediatric wheezing/bronchospasm (MoH Paediatric Protocols):
β’ Assessment: Re-evaluate in 15β30 minutes.
β’ If symptoms resolve, continue SABA Q4H PRN. Review inhaler technique and asthma action plan.
π’ Mild Acute Exacerbation (MoH Triage)
MoH CPG ProtocolClinical Presentation: Normal mental status, speaks in sentences, mild chest indrawing, tachypneic, SpOβ β₯ 95% on room air.
β οΈ Moderate Acute Exacerbation (MoH Triage)
MoH CPG ProtocolClinical Presentation: Speaks in phrases/partial sentences, moderate subcostal/intercostal recessions, tracheal tug, SpOβ 92β94% on room air.
π¨ Severe / Impending Respiratory Arrest (MoH Triage)
Red Zone / ResusClinical Presentation: Unable to speak/cry, drowsy/confused, exhausted, marked subcostal/sternal retractions, cyanosis, "silent chest", SpOβ < 92% on room air.
Anaphylaxis: IM Adrenaline (1:1,000)
IM ONLY0.01 mg/kg (= 0.01 mL/kg of 1 mg/mL)
Seizure: Rectal Diazepam
RECTAL0.5 mg/kg (Max: 10 mg)
Shock: Normal Saline 0.9% Bolus
IV PUSH20 mL/kg (10 mL/kg in DHF/Cardiac/Renal)
Hypoglycaemia: Dextrose 10% IV
IV STAT5 mL/kg (0.5 g/kg glucose - Rule of 50)
IV Hydrocortisone (Solu-Cortef)
Inject 2.0 mL Sterile Water into 100 mg vial. Mix gently to yield 50 mg/mL.
Draw -- mL. Top up with -- mL Normal Saline 0.9% into a 10 mL syringe.
Push slowly over 3 to 5 minutes.
Never rapid bolus or infuse with plain water.
WHO / MoH Standard: Formula Age Γ 2 + 8 for 1β5 yrs, WHO Growth Standard medians for >5 yrs.
| Age | Boys (Median) | Girls (Median) | Formula / Guide |
|---|---|---|---|
| 1 Month | 4.5 kg | 4.2 kg | (Months Γ 0.5) + 4 |
| 6 Months | 7.9 kg | 7.3 kg | (Months Γ 0.5) + 4 |
| 1 Year | 9.6 kg | 8.9 kg | Age Γ 2 + 8 |
| 2 Years | 12.2 kg | 11.5 kg | Age Γ 2 + 8 |
| 3 Years | 14.3 kg | 13.9 kg | Age Γ 2 + 8 |
| 4 Years | 16.3 kg | 16.1 kg | Age Γ 2 + 8 |
| 5 Years | 18.3 kg | 18.2 kg | Age Γ 2 + 8 |
| 6 Years | 20.5 kg | 20.2 kg | WHO Growth Standard |
| 7 Years | 23.1 kg | 22.8 kg | WHO Growth Standard |
| 8 Years | 25.6 kg | 25.6 kg | WHO Growth Standard |
| 10 Years | 31.9 kg | 32.5 kg | WHO Growth Standard |
| 12 Years | 39.8 kg | 41.5 kg | WHO Growth Standard |
Estimate expected pediatric age range from weight using WHO percentile tables.
| Weight Band | Estimated Age | Standard Development Stage |
|---|---|---|
| 3.0 β 5.0 kg | 0 β 2 Months | Early Neonatal / Infant |
| 5.1 β 7.5 kg | 2 β 6 Months | Young Infant |
| 7.6 β 9.5 kg | 6 β 12 Months | Older Infant |
| 9.6 β 12.5 kg | 1 β 2 Years | Toddler |
| 12.6 β 15.0 kg | 2 β 3.5 Years | Early Preschool |
| 15.1 β 18.5 kg | 3.5 β 5 Years | Preschool |
| 18.6 β 23.0 kg | 5 β 7 Years | Early Primary |
| 23.1 β 28.0 kg | 7 β 9 Years | Primary School |
| 28.1 β 35.0 kg | 9 β 11 Years | Late Primary |
| 35.1 β 45.0 kg | 11 β 13 Years | Early Adolescent |
| > 45.0 kg | > 13 Years | Adolescent / Adult Dosing |
π‘ MoH Neonatal Jaundice (NNJ) Nomogram
CPG 2014 2nd EdMalaysian MoH clinical risk stratification (0β168 Hours / Day 1β7) with dynamic cutoff curves.
π§ Pediatric Maintenance & Rehydration Fluids
Holliday-Segar (100/50/20 Rule) + MoH Dehydration Deficit replacement protocol.
π¦ MoH Pediatric Dengue Fluid Management
MoH CPG 3rd Ed24-Hour fluid quota & stepped titration rates for critical phase plasma leakage.
For Registered Healthcare Professionals only. PaedsCalc serves as a point-of-care clinical calculation aid. Dosing parameters and formulation data are synthesized from authoritative pediatric guidelines. All computed doses must be independently verified against patient-specific clinical parameters, renal/hepatic function, and institutional protocols prior to drug administration.